Xerthra(TM) kits

Information

Xerthra(TM) is a family of high-performance separation devices for preparing autologous, blood-derived injectable products. Made from Makrolon(R) polycarbonate with very low surface energy, Xerthra(TM) minimizes protein/cell binding to the device surface — unlike tube-based kits — ensuring maximum recovery of platelets and growth factors and full clinical functionality.Key features include a semi-closed pressure-equalization system for safe blood transfer, stabilizing rings for balanced centrifugation and hemolysis protection, and precise volume markings (1/2/3 mL) with transparent phase observation.Xerthra(TM) delivers up to 9.7x platelet concentration and 2.2x WBC increase vs. baseline, with over 95% RBC reduction — exceeding the 1,000,000 PLT/MuL therapeutic threshold and 5x more concentrated than tube-based kits.
Product Categories
  • Finished Dosage Forms
    • Packaging Materials and Equipment
      • Medical Devices and Medical Packaging
      Distribution Areas
      OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
      Supplied From
      Poland

      Log in

      See all the content and easy-to-use features by logging in or registering!